butabarbital will decrease the level or outcome of doravirine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. butabarbital will lessen the extent or result of estrogens esterified by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. butabarbit